Healthcare Brew’s Post

*Transforming Clinical Trials: WHO's New Global Guidance* The World Health Organization's latest guidance on clinical trials marks a significant shift towards more effective, equitable, and transparent research. This landmark document addresses long-standing challenges, paving the way for: A more representative participant landscape, tackling health disparities and ensuring treatments work for all populations. Enhanced transparency and data sharing, fostering collaboration and accelerating innovation. Improved trial design and methodology, streamlining the development of lifesaving treatments. Stronger regulatory oversight, safeguarding participant safety and trust. Better alignment with global health priorities, tackling pressing health concerns. These guidelines will reshape the clinical research landscape, driving: More inclusive and impactful studies Faster development of effective treatments Enhanced collaboration and knowledge sharing As we embark on this new era in clinical trials, I envision immense potential for improved health outcomes, reduced disparities, and accelerated medical breakthroughs. #ClinicalTrials #WHO #GlobalHealth #MedicalResearch #HealthEquity #Transparency #Innovation"

How can clinical evidence generation transform to better align with #healthcare demands? A recent Clinical Trials Transformation Initiative (CTTI), DCRI, Duke-Margolis Institute for Health Policy & Protas publication offers new insights on practices to improve and modernize the evidence generation system. https://bit.ly/47wqdxA #clinicaltrials #clinicalresearch #evidencegeneration

Join us to explore how we can collectively build a more trustworthy and impactful #health system and elevate the UK #LifeSciences sector. Recent studies in the UK have highlighted public sentiments when it comes to #vaccines and #clinicalresearch. Understanding public concerns about vaccines is crucial, as effective communication and trust-building can help individuals make informed health decisions. Clinical research plays a crucial role in providing #evidence on vaccine safety and efficacy, which reinforces #public #confidence. To enhance vaccine uptake and address hesitancy, collaboration between health authorities and researchers is vital. At this summit, we will address these critical issues through expert panels and insightful discussions aimed at building a more #trustworthy and #effective health system. Panel 1: ➡️ Chair: Professor Azeem Majeed , Imperial College London ➡️ Dr. Andrew Cai, Medical Director, CSL Seqirus ➡️ Dr. Nicola Lang, Director of Public Health, Hammersmith & Fulham Council ➡️ Dr. Philip Cruz, Country Medical Director, Moderna UK ➡️ Phayza Fudlalla, BME Health Forum Panel 2: ➡️ Chair: Dr. Bob Klaber , Imperial College Healthcare NHS Trust ➡️ Dr. Keerti Gedela, EDI Lead, NIHR CRN North West London ➡️ Luke Devey, Chief Medical Officer, Quell Therapeutics ➡️ Naima Adan, Community Engagement Officer, PERC ➡️ Pauline Hakutangwi (She/Her), Patient Engagement Representative, Novartis UK 🎟 Secure your spot: https://lnkd.in/dFjdpjYB #JawdropFireside24 #HealthOutcomes #LifeSciences #TrustInHealthcare #UKHealth #VaccineHesitancy White City Innovation District Hammersmith & Fulham Council Imperial College London Imperial Enterprise Royce at Imperial

How do we convince the population that taking part in clinical trials means getting access to better treatment? How do we make sure that the benefit of an innovation district riverberates across all layers of the population, not just to those in the shiny buildings? How do we go about building, and sometimes re-building trust? If you want to try to answer these crucial questions, this is the event.

🌍 Strengthening Clinical Trials Globally! 🌍 The WHO has issued new guidelines aimed at improving clinical trials across all countries, focusing on transparency, quality, and ethical standards. These guidelines are essential for enhancing the reliability of trial outcomes and ensuring that patient safety is prioritized. As professionals in the healthcare sector, it’s crucial that we stay informed about these developments and work together to implement best practices in our research efforts. This initiative not only promotes innovation but also builds trust in the clinical research process. Read more about these important guidelines here: Sushmita Panda Sakshi Kuchroo Sumana Sarkar Syed Fazal Bari Roshun Povaiah World Health Organization Parexel #ClinicalTrials #Healthcare #WHO #Research #PublicHealth #Innovation

The healthcare industry is shifting towards patient-centered care and centralized data management. Tiga Healthcare Technologies user-friendly Personal Health Record (PHR) System and our ongoing partnerships, which focus on patient engagement, solidify our leadership in the evolving healthcare IT framework. Thanks to PHR, patients securely access their health records 24/7, boosting patient-centered care and more informed decision-making processes. Patients, healthcare professionals and authorities benefit from real-time information and powerful data management. Our PHR delivers more than these advantages and aligns with recent research, such as European Parliament's recent policy options on multi-country collaboration for rare diseases. Among the six policy options for rare diseases, utilizing electronic health records and secure access to real-time medical data for patients is essential. In essence, PHR opens the road for us to lead patient-centered healthcare IT. It streamlines healthcare delivery for impactful solutions globally. Let's shape the future together, as always! More on the European Parliament report on rare diseases: https://lnkd.in/dCZ4qJAV #Tiga #HealthcareIT #PharmaIT #PHR #PatientEngagement

On day 2 of the #RC74CPH, it was an honour and a privilege to deliver a joint statement on behalf of European Patients' Forum and 11 other organisations to express our strong support for the WHO Regional Office for Europe Engagement Plan with Non-State Actors. 🏥 As our HC systems face growing challenges, inclusive health governance is critical to ensure that health policies meet people’s needs, in line with the #WHA77 Resolution on Social Participation. 📢 Civil society organisations bring to the public debate the voices of patients, carers, professionals, people with lived experiences, and many others. ✏️ The Plan brings together established workstreams and ambitious new goals. The very process of its development is a model of early engagement, co-creation, and respectful dialogue. 📈 We propose collaborating on a monitoring framework with clearly defined short-term outcomes and longer-term targets. What gets measured gets done! 💰 We call on WHO and MS to help address challenges to the sustainability of CSOs. MS must allocate budgets and reliable and transparent sources of funding to sustain this dialogue. 🤝 We look forward to working with WHO to translate it into concrete actions and work together towards better health outcomes for all and more equitable HC systems. Read the full statement here: https://lnkd.in/ewzgvXSB And the NSA Engagement Plan: https://lnkd.in/eunzdynj EUROCAM, The European Federation of the Associations of Dietitians (EFAD), EFNNMA, European Public Health Alliance (EPHA), International Diabetes Federation Europe, IFMSA | International Federation of Medical Students' Associations, ISPRM , International Society for Telemedicine & eHealth, Movendi International, Women in Global Health, World Federation of Hemophilia / Fédération mondiale de l'hémophilie

There is much to say about the recent release of this WHO guide. Most importantly, it is a critical step toward more inclusive and equitable clinical trials, addressing long-standing issues like poor trial design, lack of diversity, and under-representation of low- and middle-income countries. By promoting stronger country-led research and ensuring broader participation, this guidance aims to accelerate access to safe, effective health interventions globally. https://lnkd.in/eM9UbtsD

The NEJM Catalyst selected our article as one of the most popular articles of the year 2024! 🙂 In this article, a collaboration of 26 representatives of PROMIS National Centers across the world, we discuss the value or #PROMIS for international standardization of PROs and PROMs, to accelerate patient-centered care across health conditions, settings, and countries. Have you not read the paper yet? Here is a free link: https://lnkd.in/eTdQJ89T

On day 2 of the #RC74CPH, The European Federation of the Associations of Dietitians (EFAD) endorsed a joint statement on the NSA Engagement Plan, co-signed by the European Patients' Forum and other key stakeholders, underscoring the importance of inclusive governance in healthcare. This plan, designed in collaboration with civil society organizations, promotes transparency, trust, and participatory policy-making across WHO Regional Office for Europe 👉🏻 Read the full Joint Statement: https://lnkd.in/dPWy7Nsb